title: Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity.
abstract: Hepatocyte growth factor (HGF) is a potent mitogen, motogen, and morphogen for various epithelial cell types. The pleiotropic effects of HGF are mediated by its binding to a specific high affinity receptor, c-Met. In addition, HGF binds to heparan sulfate proteoglycans on cell surfaces and within the extracellular matrix. Incubation of HGF with 0.1, 1.0, and 10 micrograms/ml of heparin, heparan sulfate, or dextran sulfate resulted in a concentration-dependent increase in mitogenic potency in a primary rat hepatocyte bioassay, whereas sodium sulfate or fucoidan did not. Although co-incubation of HGF with sulfated compounds that enhanced HGF-dependent mitogenesis did not alter the binding isotherm of HGF for the c-Met receptor in a solid phase assay, an increase in autophosphorylation of the c-Met receptor in intact A549 cells was observed upon their addition. A series of chemically sulfated malto-oligosaccharides varying in unit size and charge was tested in the bioassay in order to provide additional insights into the nature of the HGF-heparin interaction. While sulfated di-, tri-, tetra-, and pentasaccharides did not significantly potentiate HGF-dependent mitogenesis, larger oligosaccharides such as the sulfated hexa-, hepta-, or a sulfated oligosaccharide mixture containing decasaccharides resulted in an approximate 2-, 4-, and 7-fold enhancement, respectively. We observed a correlation between the sulfated oligosaccharide preparations that enhanced mitogenic potency and those that promoted HGF oligomerization in vitro, as measured by gel filtration and analytical ultracentrifugation. These findings indicate that heparin-like molecules can stabilize HGF oligomers, which may facilitate c-Met receptor dimerization and activation.
authors.affiliation: Genentech, Inc., South San Francisco, California 94080-4990, USA.
authors.forename: T F
authors.initials: TF
authors.lastname: Zioncheck
authors.forename: L
authors.initials: L
authors.lastname: Richardson
authors.forename: J
authors.initials: J
authors.lastname: Liu
authors.forename: L
authors.initials: L
authors.lastname: Chang
authors.forename: K L
authors.initials: KL
authors.lastname: King
authors.forename: G L
authors.initials: GL
authors.lastname: Bennett
authors.forename: P
authors.initials: P
authors.lastname: Fügedi
authors.forename: S M
authors.initials: SM
authors.lastname: Chamow
authors.forename: R H
authors.initials: RH
authors.lastname: Schwall
authors.forename: R J
authors.initials: RJ
authors.lastname: Stack
mesh_terms: D000818:Animals; D004247:DNA / Q000096:biosynthesis; D016264:Dextran Sulfate / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D006497:Heparan Sulfate / Q000494:pharmacology; D017228:Hepatocyte Growth Factor / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D008934:Mitogens / Q000494:pharmacology*; D009844:Oligosaccharides / Q000494:pharmacology*; D010766:Phosphorylation; D019859:Proto-Oncogene Proteins c-met; D051381:Rats; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D011994:Recombinant Proteins / Q000494:pharmacology; D013431:Sulfates / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D004247:DNA; D016264:Dextran Sulfate; D006493:Heparin; D006497:Heparan Sulfate; D017228:Hepatocyte Growth Factor; D008934:Mitogens; D009844:Oligosaccharides; D019859:Proto-Oncogene Proteins c-met; D020794:Receptor Protein-Tyrosine Kinases; D011994:Recombinant Proteins; D013431:Sulfates